Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Apixaban by Taho Pharmaceuticals for Pulmonary Embolism: Likelihood of Approval
Apixaban is under clinical development by Taho Pharmaceuticals and currently in Phase I for Pulmonary Embolism. According to GlobalData, Phase...